Targeting TOP2A in Ovarian Cancer: Biological and Clinical Implications.

MLA

Borella, Fulvio, et al. “Targeting TOP2A in Ovarian Cancer: Biological and Clinical Implications.” Current Oncology (Toronto, Ont.), vol. 31, no. 12, Dec. 2024, pp. 8054–74. EBSCOhost, https://doi.org/10.3390/curroncol31120594.

APA

Borella, F., Fucina, S., Seminara, Y., Denti, P., Ferraioli, D., Bertero, L., Gallio, N., Cusato, J., Valabrega, G., Revelli, A., Marozio, L., & Cosma, S. (2024). Targeting TOP2A in Ovarian Cancer: Biological and Clinical Implications. Current Oncology (Toronto, Ont.), 31(12), 8054–8074. https://doi.org/10.3390/curroncol31120594

Chicago

Borella, Fulvio, Stefano Fucina, Ylenia Seminara, Pietro Denti, Domenico Ferraioli, Luca Bertero, Niccolò Gallio, et al. 2024. “Targeting TOP2A in Ovarian Cancer: Biological and Clinical Implications.” Current Oncology (Toronto, Ont.) 31 (12): 8054–74. doi:10.3390/curroncol31120594.